Literature DB >> 24013737

Pipeline for COPD drugs flows with combination candidates.

Helen Thompson.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24013737     DOI： 10.1038/nm0913-1079

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study.

Authors:  Claus F Vogelmeier; Eric D Bateman; John Pallante; Vijay K T Alagappan; Peter D'Andrea; Hungta Chen; Donald Banerji
Journal:  Lancet Respir Med       Date:  2012-12-06       Impact factor: 30.700
  1 in total
  3 in total

1.  Complex diseases require complex therapies.

Authors:  Ravi Iyengar
Journal:  EMBO Rep       Date:  2013-11-15       Impact factor: 8.807

2.  Systems Pharmacology and Rational Polypharmacy: Nitric Oxide-Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General Case.

Authors:  Farshid S Garmaroudi; Diane E Handy; Yang-Yu Liu; Joseph Loscalzo
Journal:  PLoS Comput Biol       Date:  2016-03-17       Impact factor: 4.475

Review 3.  Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases.

Authors:  Heng Li; Jianping Zuo; Wei Tang
Journal:  Front Pharmacol       Date:  2018-10-17       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.